Risk of venous thromboembolism in patients receiving adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide for early breast cancer
Aim: Previous studies have shown that adjuvant chemotherapy in early breast cancer (EBC) may increase the risk of venous thromboembolism (VTE). Clinical experience suggests the combination of 5-fluorouracil, epirubicin and cyclophosphamide (FEC) may be associated with a higher frequency of VTE than other regimens. This study aims to investigate the use of adjuvant FEC compared with other adjuvant regimens in the development of VTE in patients with EBC. Methods: A retrospective auditwas...[Show more]
|Collections||ANU Research Publications|
|Source:||Asia-Pacific Journal of Clinical Oncology|
|01_Hoy_Risk_of_venous_thromboembolism_2009.pdf||113.18 kB||Adobe PDF||Request a copy|
|02_Hoy_Risk_of_venous_thromboembolism_2009.pdf||84.25 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.